Enterobacteriaceae Infection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-07-24
Clinical Trial Update: PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections [Phase 4]
A Phase 4 trial comparing pipercillin/tazobactam against meropenem for AmpC-producing bloodstream infections has been withdrawn.